Literature DB >> 12729315

Clinical research in family medicine: quantity and quality of published articles.

Joel Merenstein1, Goutham Rao, Frank D'Amico.   

Abstract

BACKGROUND AND OBJECTIVES: Publication of clinical research in peer-reviewed journals is an important measure of scholarly productivity. This study determined the quantity and quality of original clinical research published by family physicians.
METHODS: We surveyed clinical research papers published in the year 2000 in four leading family medicine research journals and research originating in a family practice institution but published in 16 non-family medicine journals. All were selected on the basis of relevance to family physicians and "impact factor." The relevance and validity of papers was assessed using previously established criteria.
RESULTS: The survey of family medicine journals revealed a total of 170 original research articles. Ninety eight were from academic family practice programs, and the remaining 72 were from other medical specialties or health care institutions. Most of the papers were cross-sectional surveys. There were seven qualitative studies, six randomized controlled trials, and no systematic reviews from family practice programs in these journals. Eight of the articles were from practice-based research networks. A total of 79 articles were considered relevant or highly relevant, and 22 of these were also considered valid (Patient-oriented Evidence That Matters or POEMs). The survey of 16 non-family medicine journals revealed 37 clinical research papers: 16 surveys, nine prospective cohort studies, seven randomized controlled trials, three systematic reviews/meta-analysis, one qualitative study, and one case-control study. There were nine "highly relevant" papers--seven could be classified as POEMs.
CONCLUSIONS: Most clinical family medicine research uses less-rigorous study designs, such as the cross-sectional survey. The majority of papers do not meet established criteria for relevance and validity. There are no standards or comparable studies to compare these results to prior years or to other disciplines.

Entities:  

Mesh:

Year:  2003        PMID: 12729315

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  7 in total

1.  Family medicine residents’ barriers to conducting scholarly work.

Authors:  Femi Bammeke; Clare Liddy; Matthew Hogel; Douglas Archibald; Ziad Chaar; Robin MacLaren
Journal:  Can Fam Physician       Date:  2015-09       Impact factor: 3.275

2.  BUILDING RESEARCH & SCHOLARSHIP CAPACITY IN DEPARTMENTS OF FAMILY MEDICINE: A NEW JOINT ADFM-NAPCRG INITIATIVE.

Authors:  Bernard Ewigman; Ardis Davis; Tom Vansaghi; Allison Cole; Frank deGruy; Lee Green; Dana King; Tony Kuzel; Erik Lindbloom; Lynn Meadows; Fred Miser; Donald Nease; Mack Ruffin
Journal:  Ann Fam Med       Date:  2016 Jan-Feb       Impact factor: 5.166

3.  Residency research requirements and the CanMEDS-FM scholar role: perspectives of residents and recent graduates.

Authors:  Jonathan Koo; Jason Bains; Marisa B Collins; Shafik Dharamsi
Journal:  Can Fam Physician       Date:  2012-06       Impact factor: 3.275

4.  The profile of general practitioners (GPs) who publish in selected family practice journals.

Authors:  J Soler-González; C Ruiz; C Serna; J R Marsal
Journal:  BMC Res Notes       Date:  2011-05-26

5.  Clinical research quo vadis? Trends in reporting of clinical trials and observational study designs over two decades.

Authors:  Moritz C Wyler von Ballmoos; James H Ware; Bernhard Haring
Journal:  J Clin Med Res       Date:  2015-04-08

6.  Comparison of research trends in korean and international family medicine in journals of family medicine.

Authors:  Jin-Kyung Jeon; Jungun Lee; Dong Ryul Lee
Journal:  Korean J Fam Med       Date:  2014-11-21

7.  Analysis of evidence appraisals for interventional studies in family medicine using an informatics approach.

Authors:  Alain Nathan Sahin; Andrew Goldstein; Chunhua Weng
Journal:  Prim Health Care Res Dev       Date:  2019-08-22       Impact factor: 1.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.